Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis

Osteoporosis International

Volumn 19, Issue 7, 2008, Pages 969-978

  Delany, A M ^a   McMahon, D J ^b   Powell, J S ^b   Greenberg, D A ^c   Kurland, E S ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c NONE   (United States)

Author keywords

3 Untranslated region; Bone mineral density; Idiopathic osteoporosis; Non collagen matrix protein; Osteonectin SPARC; SNP polymorphism

Indexed keywords

GENOMIC DNA; OSTEONECTIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BONE DENSITY; CHI SQUARE TEST; CONTROLLED STUDY; FISHER EXACT TEST; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; IDIOPATHIC OSTEOPOROSIS; MAJOR CLINICAL STUDY; MALE; OSTEOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL;

ADULT; BONE DENSITY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HIP; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEONECTIN; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIUS;

EID: 44649115131     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0523-9     Document Type: Article

References (38)

1. Stewart TL, Ralston SH (2000) Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 166:235-245
2. Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP (1997) Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:2799-2805
3. Kurland ES, Chan FK, Rosen CJ, Bilezikian JP (1998) Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 83:2576-2579
4. Cardon LR, Garner C, Bennett ST, Mackay IJ, Edwards SM, Cornish J, Hegde M, Murray MAF, Reid IR, Cundy T (2000) Evidence for a major gene for bone mineral density in idiopathic osteoporotic families. J Bone Miner Res 15:1132-1137
5. Van Pottelbergh I, Goemaere S, Zmierczak H, Kaufman JM (2004) Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J Clin Endocrinol Metab 89:4949-4953
6. Evans SF, Davie MWJ (2002) Low body size and elevated sex-hormone binding globulin distinguish men with idiopathic vertebral fracture. Calcif Tissue Int 70:9-15
7. Kurland ES, Khosla S, Colvin TL, Heller SL, Powell J, Seltzer B, McMahon D, Bilezikian JP (2003) The relative role of the sex steroids in idiopathic osteoporosis in men. J Bone Miner Res 18(Suppl):SA331 (abstract)
8. Giguere Y, Rousseau F (2000) The genetics of osteoporosis: "complexities and difficulties" Clin Genet 57:161-169
9. Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049-1054
10. Barker TH, Baneyx G, Cardo-Vila m, Workman GA, Weaver M, Menon PM, Dedhar S, Rempel SA, Arap W, Pasqualini R, Vogel V, Sage EH (2005) SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase. J Biol Chem 280:36483-36493
11. Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E (2000) Osteopenia and decreased bone formation in osteonectin-null mice. J Clin Invest 105:915-923
12. Kessler C, Delany AM (2007) Increased notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts. Endocrinology 148:1666-1674
13. Fedarko NS, Moerike M, Brenner R, Gehron Robey P, Vetter U (1992) Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 7:921-930
14. Fedarko NS, Gehron Robey P, Vetter UK (1995) Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 10:1122-1129
15. Muriel MP, Bonaventure J, Stanescu R, Maroteaux P, Guenet JL, Stanescu V (1991) Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility. Bone 12:241-248
16. Fisher LW, Drum MA, Gehron Robey P, Conn KM, Termine JD (1987) Osteonectin content in human osteogenesis imperfecta bone shows a range similar to that of two bovine models of OI. Calcif Tissue Int 40:260-264
17. Kessler C, Delany AM (2006) Osteonectin/SPARC is critical for anabolic response to PTH in the skeleton. J Bone Miner Res 21S1:S134
18. Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E (2003) Osteonectin-null mutation compromises osteoblast formation, maturation and survival. Endocrinology 144:2588-2596
19. Mendell JT, Dietz HC (2001) When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell 107:411-414
20. Zhou X, Tan FK, Reveille JD, Wallis D, Milewicz DM, Ahn C, Wang A, Arnett FC (2002) Association of novel polymorphisms with expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 46:2900-2999
21. Lagan AL, Pantelidis P, Renzoni EA, Fonseca C, Beirne P, Taegtmeyer AB, Denton CP, Black CM, Wells AU, duBios RM, Welsh KI (2005) Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma. Rheumatology 44:197-201
22. Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformantics methods and protocols: methods in molecular biology. Humana Press, Totowa, NJ, pp 365-386
23. Evans AL, Brice G, Sotirova V, Mortimer P, Beninon J, Burnand K, Rosbotham J, Chile A, Sarfarazi M (1999) Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 64:547-555
24. Bassam BJ, Caitano-Annoles G, Gresshoff PM (1991) Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196:80-83
25. Barrett-Connor E, Siris ES, Wehren LE, Miller PD, Abbott TA, Berger ML, Santora AC, Sherwood LM (2005) Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 20:185-194
26. Swaroop A, Hogan BL, Franke U (1988) Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression and localization of the gene to chromosome 5q31-33. Genomics 2:37-47
27. Villarreal XC, Mann KG, Long GL (1989) Structure of human osteonectin based upon analysis of cDNA and genomic sequences. Biochemistry 28:6483-6491
28. Bolander ME, Young MF, Fisher LW, Yamada Y, Termine JD (1988) Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor. Proc Natl Acad Sci USA 85:2919-2923
29. McVey JH, Nomura S, Kelly P, Mason IJ, Hogan BL (1988) Characterization of the mouse SPARC/osteonectin gene. J Biol Chem 263:11111-11116
30. Liu Y-J, Shen H, Xiao P, Xiong D-H, Li L-H, Recker RR, Deng H-W (2006) Molecular genetic studies of gene identification for osteoporosis. A 2004 update. J Bone Miner Res 21:1511-1535
31. Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D'Agostino D, Jannausch M (1998) Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695-705
32. Ibaraki K, Gehron Robey P, Young MF (1993) Partial characterization of a novel "GGA" factor which binds to the osteonectin promoter in bovine bone cells. Gene 130:225-232
33. Hafner M, Zimmermann K, Pottgiesser J, Kreig T, Nischt R (1995) A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription. Matrix Biol 14:733-741
34. Dominguez P, Ibaraki K, Gehron Robey P, Hefferan TE, Termine JD, Young MF (1991) Expression of the osteonectin gene potentially controlled by multiple cis- and trans-acting factors in cultured bone cells. J Bone Miner Res 6:1127-1136
35. Nomura S, Hashmi S, McVey JH, Ham J, Parker M, Hogan BLM (1989) Evidence for positive and negative regulatory elements in the 5'-flanking sequence of the mouse SPARC (osteonectin) gene. J Biol Chem 264:12201-12207
36. Wrana JL, Overall CM, Sodek J (1991) Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β. Eur J Biochem 197:519-528
37. Ng KW, Manji SS, Young MF, Findlay DM (1989) Opposing influences of glucocorticoid and retinoic acid on transcriptional control in preosteoblasts. Mol Endocrinol 3:2079-2085
38. Delany AM, Canalis E (1998) Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts. Am J Physiol 274 (Cell Physiol. 43) C734-C740